Literature DB >> 30032209

Does Combined Osteopenia/Osteoporosis and Sarcopenia Confer Greater Risk of Falls and Fracture Than Either Condition Alone in Older Men? The Concord Health and Ageing in Men Project.

David Scott1,2, Markus Seibel3,4, Robert Cumming5,6,7, Vasi Naganathan6, Fiona Blyth6, David G Le Couteur8,9, David J Handelsman8,10, Louise M Waite6, Vasant Hirani6,11.   

Abstract

BACKGROUND: It is unclear whether older men with osteopenia/osteoporosis and sarcopenia (so-called osteosarcopenia) are at greater risk of falls and fractures than those with either condition alone.
METHODS: One thousand five hundred seventy-five community-dwelling men aged ≥70 years had appendicular lean mass, total hip and lumbar spine bone mineral density determined by dual-energy x-ray absorptiometry, and completed hand grip strength and gait speed tests. Osteopenia/osteoporosis was defined as a T-score at any site ≤-1.0 SD. Sarcopenia was defined using the European Working Group on Sarcopenia algorithm. Participants were contacted every 4 months for 6 ± 2 years to ascertain incident fractures (confirmed by radiographic reports) and for 2 years for incident falls.
RESULTS: Prevalence of osteosarcopenia was 8%, while 34% of participants had osteopenia/osteoporosis alone and 7% had sarcopenia alone. Men with osteosarcopenia had significantly increased fall (incidence rate ratio: 1.41; 95% confidence interval [CI]: 1.02 to 1.95) and fracture risk (hazard ratio: 1.87; 95% CI: 1.07 to 3.26) compared with men with neither osteopenia/osteoporosis nor sarcopenia. There was no statistical interaction between osteopenia/osteoporosis and sarcopenia, and falls and fracture risk were not different for osteosarcopenia compared with either condition alone (all p > .05).
CONCLUSIONS: Community-dwelling older men with combined osteopenia/osteoporosis and sarcopenia do not have increased falls and fracture risk compared with those with either condition. Further research is required to clarify whether the term "osteosarcopenia" has any meaning above and beyond either term alone and therefore potential clinical utility for falls and fracture prediction.
© The Author(s) 2018. Published by Oxford University Press on behalf of The Gerontological Society of America. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Bone aging; Falls; Hip fracture; Muscle; Osteosarcopenia

Mesh:

Substances:

Year:  2019        PMID: 30032209     DOI: 10.1093/gerona/gly162

Source DB:  PubMed          Journal:  J Gerontol A Biol Sci Med Sci        ISSN: 1079-5006            Impact factor:   6.053


  17 in total

Review 1.  Osteosarcopenia: the Path Beyond Controversy.

Authors:  Jesse Zanker; Gustavo Duque
Journal:  Curr Osteoporos Rep       Date:  2020-04       Impact factor: 5.096

Review 2.  Role of MicroRNA-141 in the Aging Musculoskeletal System: A Current Overview.

Authors:  Babatunde Fariyike; Quante Singleton; Monte Hunter; William D Hill; Carlos M Isales; Mark W Hamrick; Sadanand Fulzele
Journal:  Mech Ageing Dev       Date:  2018-12-07       Impact factor: 5.432

Review 3.  Bone health in ageing men.

Authors:  Karel David; Nick Narinx; Leen Antonio; Pieter Evenepoel; Frank Claessens; Brigitte Decallonne; Dirk Vanderschueren
Journal:  Rev Endocr Metab Disord       Date:  2022-07-16       Impact factor: 9.306

4.  Computed tomography-based paravertebral muscle density predicts subsequent vertebral fracture risks independently of bone mineral density in postmenopausal women following percutaneous vertebral augmentation.

Authors:  Hao Chen; Shu-Bao Zhang; Hao-Wei Xu; Yu-Yang Yi; Xin-Yue Fang; Shan-Jin Wang
Journal:  Aging Clin Exp Res       Date:  2022-08-24       Impact factor: 4.481

Review 5.  The analysis of osteosarcopenia as a risk factor for fractures, mortality, and falls.

Authors:  Z Teng; Y Zhu; Y Teng; Q Long; Q Hao; X Yu; L Yang; Y Lv; J Liu; Y Zeng; S Lu
Journal:  Osteoporos Int       Date:  2021-04-20       Impact factor: 4.507

6.  Low energy irradiation of narrow-range UV-LED prevents osteosarcopenia associated with vitamin D deficiency in senescence-accelerated mouse prone 6.

Authors:  Kazuya Makida; Yoshihiro Nishida; Daigo Morita; Satoshi Ochiai; Yoshitoshi Higuchi; Taisuke Seki; Kunihiro Ikuta; Naoki Ishiguro
Journal:  Sci Rep       Date:  2020-07-17       Impact factor: 4.379

7.  Bone Mass Loss and Sarcopenia in Ecuadorian Patients.

Authors:  M Intriago; G Maldonado; R Guerrero; O D Messina; C Rios
Journal:  J Aging Res       Date:  2020-03-17

8.  Biomarkers of sarcopenia in very old patients with hip fracture.

Authors:  Carmen Sánchez-Castellano; Sagrario Martín-Aragón; Paloma Bermejo-Bescós; Nieves Vaquero-Pinto; Carmen Miret-Corchado; Ana Merello de Miguel; Alfonso José Cruz-Jentoft
Journal:  J Cachexia Sarcopenia Muscle       Date:  2020-01-08       Impact factor: 12.910

9.  Osteosarcopenia: epidemiology, diagnosis, and treatment-facts and numbers.

Authors:  Ben Kirk; Jesse Zanker; Gustavo Duque
Journal:  J Cachexia Sarcopenia Muscle       Date:  2020-03-22       Impact factor: 12.910

10.  Nutrition Mediates the Relationship between Osteosarcopenia and Frailty: A Pathway Analysis.

Authors:  Justin Chew; Audrey Yeo; Suzanne Yew; Cai Ning Tan; Jun Pei Lim; Noor Hafizah Ismail; Wee Shiong Lim
Journal:  Nutrients       Date:  2020-09-27       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.